Harvard Bioscience Inc
NASDAQ:HBIO
Harvard Bioscience Inc
NASDAQ:HBIO
Price:
3.85 USD
0.79%
Updated:
May 6, 2024
Harvard Bioscience Inc
Cash from Investing Activities
|
Harvard Bioscience Inc
Cash from Investing Activities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Harvard Bioscience Inc
NASDAQ:HBIO
|
Cash from Investing Activities
-$1.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Investing Activities
-$5.1B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-35%
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Investing Activities
-$7.1B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-18%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Investing Activities
-$131.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Investing Activities
-$301m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-3%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Investing Activities
-$1.6B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-21%
|
See Also
What is Harvard Bioscience Inc's Cash from Investing Activities?
Cash from Investing Activities
-1.8m
USD
-1.8m
USD
Based on the financial report for Dec 31, 2023, Harvard Bioscience Inc's Cash from Investing Activities amounts to -1.8m USD.
What is Harvard Bioscience Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
49%
49%
Over the last year, the Cash from Investing Activities growth was -13%. The average annual Cash from Investing Activities growth rates for Harvard Bioscience Inc have been -9% over the past three years , 49% over the past five years .
You don't have any saved screeners yet
